Bearing the above in mind, it is important to note some evidence that shows HP treatment, in as low a concentration as 0.5 μM, can lead to significantly increased level of gene and protein expression of VEGF 6 h after treatment incidence in medulloblastoma and glioblastoma. The gene discussed is VEGFA; the disease is medulloblastoma.